Yonger Xue

Yonger Xue's research focuses on designing nanoparticle- and polymer-based delivery systems to transport drugs, antibodies, and genetic material (like siRNA) to specific targets in the body, including the brain and tumors. Much of the work addresses cancer therapy, particularly glioblastoma, by combining immune-boosting treatments with engineered nanocarriers that can cross biological barriers such as the blood-brain barrier. This work sits at the intersection of materials science, drug delivery, and immunology/cancer treatment.

Publication output has grown substantially over the past decade, rising from occasional papers before 2020 to a sustained high output of 7-10 papers per year in 2023-2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026